PharmD Info

A forum for Indian Pharmacy Professionals

Important: Registered today to have the complete access on this forum --- Register Here
Discuss various Doctor of Pharmacy Knowledge based topics
  • User avatar
  • User avatar
#1891
WHAT PHARMACIST SHOULD KNOW ABOUT BIOSIMILARS?

Biosimilars are basically the generics or copies of biological medicines.The first FDA approved biosimilar was last January and was the biosimilar (filgrastim-sndz) to Neopen (filgrastim). Though filgrastim-sdnz is new to the U.S., copies have been available in the EU since 2009.

Biologics (Humira, Rituximab, Neopogen, etc) are large, complex molecules that are made from living organisms. Because of the nature of biologics, they are much harder to replicate, hence the name "similar".Biologics and biosimilars are produced in living cells with a multi-step process

Biosimilars differ from generics – in complexity, in the manufacturing processes and in the data needed to demonstrate similarity for approval

Role of the Pharmacist

Should know about the validity of extrapolating data from the innovator product to the biosimilar requires careful evaluation of the available data, especially immunogenicity data.

Health-system pharmacists can provide valuable input into decisions about use of biosimilars in the institution based on available clinical data.

A Health-System pharmacist’s Guide to Biosimilars: Regulatory, Scientific, and practical considerations biosimilar designation was established by FDA.

Pharmacovigilance: Health-system pharmacists play a vital role in the pharmacovigilance needed to detect, assess, and prevent adverse effects and other drug-related problems from biopharmaceuticals.

Health-system pharmacists can play an important role in ensuring the safe, effective, and cost-effective use of biosimilars in health systems.

As pharmacists, we need to educate our patients, physicians and other health care providers about the benefits (and possible risks) of biosimilars.

Pharmacists will need to understand the differences in all of the approval pathways to educate physicians and other clinicians on the labeling associated with each medication and the manner in which they should be used.

Pharmacists will be expected to provide leadership and guidance in balancing the financial and clinical issues associated with formulary decisions and the selection and use of these products.

Health system pharmacists whose practice settings include outpatient environments should be aware of their state’s requirements for pharmacy concerning biosimilars.

Basic information pharmacists and other clinicians must know to successfully manage the introduction of biosimilars into health systems is summarized, including manufacturing, regulatory, and medication use policy concepts.

As stewards of appropriate medication use, pharmacists must take the initiative to educate themselves, physicians, other clinicians and patients on these products to ensure an accurate understanding of this new category of drugs and to assure the safe and optimal use of biosimilars

Health-system pharmacists should take a leadership role in a multidisciplinary effort to evaluate biosimilars for use in the institution through the formulary process.

Know about the cost advantages of biosimilars may enter into formulary decisions.
#1894
The findings show that industry confidence is now extremely high, with domestic manufacturers bullish about near term revenue prospects, averaging a predicted 30.5% growth in 2017. An analysis by sector shows that, of the 400 companies, 60% believed that finished formulations would expand rapidly, while 42% see APIs as the largest growth area. Highlighting the economy's diversity and willingness to incorporate new product classes, 25% of respondents regard biosimilars and biologics as a burgeoning sector in 2017, particularly following the updated CDSCO biosimilars guidelines. :laugh:
Attachments
(3.94 MiB) Downloaded 12 times
Similar Topics
Topics Statistics Last post
PCI - Pharmacist Day Poster 2018
by Admin  - 21 Sep 2018, 17:30  - In: Newsletters & Seminars
0 Replies 
563 Views
by Admin
21 Sep 2018, 17:30
0 Replies 
545 Views
by Admin
25 Sep 2018, 10:16
7 Star Pharmacist Concept by WHO
by Admin  - 09 Sep 2017, 18:56  - In: Pharmaceutical Care
0 Replies 
918 Views
by Admin
21 Dec 2017, 11:36
PCI Pharmacist Day Poster -2017
by Admin  - 20 Sep 2017, 11:36  - In: Newsletters & Seminars
0 Replies 
1371 Views
by Admin
20 Sep 2017, 11:36
Pharmacist day Poster-2016
by Admin  - 04 Jan 2017, 21:26  - In: Newsletters & Seminars
0 Replies 
932 Views
by Admin
04 Jan 2017, 21:26

Tags

Indian Association of Colleges of Pharmacy. A/C N[…]

PharmD Info Online Group Discussion Disc[…]

PCI chalks out plans to allay concerns of educatio[…]

NAAC is in the process of developing a Manual for […]

WELCOME TO OUR E-LEARN COURSE WORK MODULES